ClinConnect ClinConnect Logo
Search / Trial NCT04194619

Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

Launched by HOSPICES CIVILS DE LYON · Dec 9, 2019

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

The COGRare5 Study is a research trial focused on understanding how rare vascular diseases can affect pregnancies. These conditions, such as Osler Rendu Disease and Marfan Syndrome, can lead to serious health issues for both mothers and their babies. The goal of this study is to learn more about potential pregnancy complications in women with these rare diseases so that doctors can improve care, reduce risks, and ultimately save lives.

To participate in this study, women between the ages of 18 and 45 who are currently pregnant or have given birth in the last month may be eligible. Participants will need to have a diagnosis of a rare vascular disease confirmed through medical tests. Those who join the study will help researchers gather important information that could lead to better guidelines for managing pregnancies in women with these conditions. It’s important to note that the study is actively recruiting participants, and women who meet the criteria are encouraged to consider joining.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women aged ≥ 18 years and ≤45 years at the time of inclusion
  • Pregnant and/or having given birth less than 1 month (≤ 30 days)
  • Clinically and/or radiological and/or molecular biology diagnosis of a rare vascular disease before or during pregnancy or one month after delivery.
  • Having been informed of all pertinent aspects of the study and provided oral non-opposition.
  • Exclusion Criteria:
  • Any person not fulfilling the inclusion criteria or refusing to take part in the study.
  • Major under legal protection

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Marseille, , France

Dijon, , France

Angers, , France

Bordeaux, , France

Boulogne Billancourt, , France

Bron, , France

Bron, , France

Bron, , France

Caen, , France

Clermont Ferrand, , France

Lille, , France

Lille, , France

Montpellier, , France

Nancy, , France

Nice, , France

Paris, , France

Paris, , France

Paris, , France

Paris, , France

Paris, , France

Poitiers, , France

Rennes, , France

Rennes, , France

Rouen, , France

Saint Herblain, , France

Saint étienne, , France

Strasbourg, , France

Suresnes, , France

Toulouse, , France

Toulouse, , France

Tours, , France

Vandœuvre Lès Nancy, , France

Bron, , France

Nantes, , France

Nice, , France

Strasbourg, , France

Strasbourg, , France

Tours, , France

Patients applied

0 patients applied

Trial Officials

Sophie DUPUIS-GIROD, MD

Principal Investigator

Service de Génétique - Hôpital Femme-Mère-Enfant - HCL

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials